Ceftriaxone, a Beta-lactam Antibiotic, Modulates Apoptosis Pathways and Oxidative Stress in a Rat Model of Neuropathic Pain

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2014 Jul 17

PMID 25028668

Citations 16

Authors

Bahareh Amin

Valiollah Hajhashemi

Khalil Abnous

Hossein Hosseinzadeh

Affiliations

Soon will be listed here.

Abstract

Purpose: In our previous study, ceftriaxone, a beta-lactam antibiotic, elicited antinociceptive effects in the chronic constriction injury (CCI) of neuropathic pain. In this study, we assessed apoptosis and oxidative stress in the spinal cord of neuropathic rats treated with ceftriaxone.

Methods: 45 male Wistar rats were divided as naïve, sham, normal saline-treated CCI rats, and CCI animals treated with the effective dose of ceftriaxone. Involvement of Bax, Bcl2, and caspases 3 and 9, important contributors of programmed cell death (apoptosis), was determined using western blotting at days 3 and 7. The markers of oxidative stress including malondialdehyde (MDA) and reduced glutathione (GSH) were measured on days 3 and 7.

Results: Increased Bax/Bcl2 ratio and cleaved active forms of caspases 3 and 9 were observed in the spinal cord of CCI rats on day 3. Ceftriaxone attenuated the increased levels of Bax and cleaved forms of caspases 3 and 9, while it increased Bcl2 levels. Bax and active forms of caspases declined by day 7. Consequently, comparison among groups showed no difference at this time. CCI enhanced MDA and decreased GSH on days 3 and 7, while ceftriaxone protected against the CCI-induced oxidative stress.

Conclusion: Our results suggest that ceftriaxone, an upregulator/activator of GLT1, could concomitantly reduce oxidative stress and apoptosis and producing its new analogs lacking antimicrobial activity may represent a novel approach for neuropathic pain treatment.

Citing Articles

Identification of Oxidative Stress-Related Biomarkers for Pain-Depression Comorbidity Based on Bioinformatics.

Zhang T, Geng M, Li X, Gu Y, Zhao W, Ning Q Int J Mol Sci. 2024; 25(15).

PMID: 39125922 PMC: 11313298. DOI: 10.3390/ijms25158353.

Electroacupuncture exerts prolonged analgesic and neuroprotective effects in a persistent dental pain model induced by multiple dental pulp injuries: GABAergic interneurons-astrocytes interaction.

Ballon Romero S, Fuh L, Hung S, Lee Y, Huang Y, Chien S Front Immunol. 2023; 14:1213710.

PMID: 37954604 PMC: 10639134. DOI: 10.3389/fimmu.2023.1213710.

A review on oxidant and antioxidant effects of antibacterial agents: impacts on bacterial cell death and division and therapeutic effects or adverse reactions in humans.

Delghandi P, Soleimani V, Bazzaz B, Hosseinzadeh H Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(10):2667-2686.

PMID: 37083711 DOI: 10.1007/s00210-023-02490-w.

Comparative neuroprotective effects of Cerebrolysin, dexamethasone, and ascorbic acid on sciatic nerve injury model: Behavioral and histopathological study.

Elhessy H, Habotta O, Eldesoqui M, Elsaed W, Soliman M, Sewilam H Front Neuroanat. 2023; 17:1090738.

PMID: 36816518 PMC: 9928760. DOI: 10.3389/fnana.2023.1090738.

Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation.

Abulseoud O, Alasmari F, Hussein A, Sari Y Front Neurosci. 2022; 16:841036.

PMID: 35864981 PMC: 9294323. DOI: 10.3389/fnins.2022.841036.

References

Pereira C, Oliveira C . Oxidative glutamate toxicity involves mitochondrial dysfunction and perturbation of intracellular Ca2+ homeostasis. Neurosci Res. 2000; 37(3):227-36. DOI: 10.1016/s0168-0102(00)00124-3. View

Hu Y, Li W, Lu L, Cai J, Xian X, Zhang M . An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats. Pain. 2009; 148(2):284-301. DOI: 10.1016/j.pain.2009.11.014. View

Macaluso A, Bernabucci M, Trabucco A, Ciolli L, Troisi F, Baldini R . Analgesic effect of a single preoperative dose of the antibiotic ceftriaxone in humans. J Pain. 2013; 14(6):604-12. DOI: 10.1016/j.jpain.2013.01.774. View

Dringen R . Metabolism and functions of glutathione in brain. Prog Neurobiol. 2000; 62(6):649-71. DOI: 10.1016/s0301-0082(99)00060-x. View

Sari Y, Sakai M, Weedman J, Rebec G, Bell R . Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats. Alcohol Alcohol. 2011; 46(3):239-46. PMC: 3104611. DOI: 10.1093/alcalc/agr023. View

Osikowicz M, Mika J, Przewlocka B . The glutamatergic system as a target for neuropathic pain relief. Exp Physiol. 2012; 98(2):372-84. DOI: 10.1113/expphysiol.2012.069922. View

Hajhashemi V, Hosseinzadeh H, Amin B . Antiallodynia and antihyperalgesia effects of ceftriaxone in treatment of chronic neuropathic pain in rats. Acta Neuropsychiatr. 2016; 25(1):27-32. DOI: 10.1111/j.1601-5215.2012.00656.x. View

Lewerenz J, Albrecht P, Tien M, Henke N, Karumbayaram S, Kornblum H . Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro. J Neurochem. 2009; 111(2):332-43. DOI: 10.1111/j.1471-4159.2009.06347.x. View

de Novellis V, Siniscalco D, Galderisi U, Fuccio C, Nolano M, Santoro L . Blockade of glutamate mGlu5 receptors in a rat model of neuropathic pain prevents early over-expression of pro-apoptotic genes and morphological changes in dorsal horn lamina II. Neuropharmacology. 2004; 46(4):468-79. DOI: 10.1016/j.neuropharm.2003.10.014. View

10.

Yogeeswari P, Semwal A, Mishra R, Sriram D . Current approaches with the glutamatergic system as targets in the treatment of neuropathic pain. Expert Opin Ther Targets. 2009; 13(8):925-43. DOI: 10.1517/14728220903029210. View

11.

Afrazi S, Esmaeili-Mahani S, Sheibani V, Abbasnejad M . Neurosteroid allopregnanolone attenuates high glucose-induced apoptosis and prevents experimental diabetic neuropathic pain: in vitro and in vivo studies. J Steroid Biochem Mol Biol. 2013; 139:98-103. DOI: 10.1016/j.jsbmb.2013.10.010. View

12.

Varija D, Kumar K, Reddy K, Reddy V . Prolonged constriction of sciatic nerve affecting oxidative stressors & antioxidant enzymes in rat. Indian J Med Res. 2009; 129(5):587-92. View

13.

Pathak N, Balaganur V, Lingaraju M, Kant V, Latief N, More A . Atorvastatin attenuates neuropathic pain in rat neuropathy model by down-regulating oxidative damage at peripheral, spinal and supraspinal levels. Neurochem Int. 2014; 68:1-9. DOI: 10.1016/j.neuint.2014.01.014. View

14.

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

15.

Rezende A, Vieira A, Rogerio F, Rezende L, Boschero A, Negro A . Effects of systemic administration of ciliary neurotrophic factor on Bax and Bcl-2 proteins in the lumbar spinal cord of neonatal rats after sciatic nerve transection. Braz J Med Biol Res. 2008; 41(11):1024-8. DOI: 10.1590/s0100-879x2008005000052. View

16.

Wu F, Miao X, Chen J, Sun Y, Liu Z, Tao Y . Down-regulation of GAP-43 by inhibition of caspases-3 in a rat model of neuropathic pain. Int J Clin Exp Pathol. 2012; 5(9):948-55. PMC: 3484482. View

17.

Rimaniol A, Mialocq P, Clayette P, Dormont D, Gras G . Role of glutamate transporters in the regulation of glutathione levels in human macrophages. Am J Physiol Cell Physiol. 2001; 281(6):C1964-70. DOI: 10.1152/ajpcell.2001.281.6.C1964. View

18.

Jelenkovic A, Jovanovic M, Stanimirovic D, Bokonjic D, Ocic G, Boskovic B . Beneficial effects of ceftriaxone against pentylenetetrazole-evoked convulsions. Exp Biol Med (Maywood). 2008; 233(11):1389-94. DOI: 10.3181/0803-RM-83. View

19.

Costa B, Siniscalco D, Trovato A, Comelli F, Sotgiu M, Colleoni M . AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain. Br J Pharmacol. 2006; 148(7):1022-32. PMC: 1751928. DOI: 10.1038/sj.bjp.0706798. View

20.

Joseph E, Levine J . Caspase signalling in neuropathic and inflammatory pain in the rat. Eur J Neurosci. 2004; 20(11):2896-902. DOI: 10.1111/j.1460-9568.2004.03750.x. View